Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Director | June 02, 2025 | June 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date June 02, 2025 · Filed June 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,116 |
Reported balance
After 2025-06-03 transaction · row 1
1 source rowRow 1 · 2025-06-03 · Exercise / conversion · Acquired 479 · Balance 10,116 |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $55.38 · Expires 2035-06-02 | Direct | 8,061 |
Reported balance
After 2025-06-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-02 · Grant · Acquired 8,061 · Balance 8,061 F1: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period. |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2035-06-02 | Direct | 668 |
Reported balance
After 2025-06-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-06-02 · Grant · Acquired 668 · Balance 668 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2034-06-03 | Direct | 0 |
Reported balance
After 2025-06-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-06-03 · Exercise / conversion · Disposed 479 · Balance 0 F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2025 Filed Jun 4, 2025 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRSUs (Restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016768 · form4.xml · derivative · entry 4 Concannon Brian · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 479 shares Expires 2034-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:40 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 479 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016768 · form4.xml · nonDerivative · entry 1 Concannon Brian · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016768 · form4.xml · derivative · entry 3 Concannon Brian · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668 Underlying: Common Stock · 668 shares Expires 2035-06-02 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:40 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 8,061 | $0.00 Strike: $55.38 | $0.00 |
DisclosureSEC source: 0001127602-25-016768 · form4.xml · derivative · entry 2 Concannon Brian · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,061 Underlying: Common Stock · 8,061 shares Expires 2035-06-02 F1 · derivative.exercise_date: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 13:33 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 479 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017863 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 479 Underlying: Common Stock · 479 shares Expires 2034-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 13:33 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 5,503 | $0.00 Strike: $77.18 | $0.00 |
DisclosureSEC source: 0001127602-24-017863 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,503 Underlying: Common Stock · 5,503 shares Expires 2034-06-03 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 13:33 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017863 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 302 shares Expires 2033-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 13:33 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017863 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2023 Filed Jun 8, 2023 20:39 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 812 | $129.01 | $104,756.12 |
DisclosureSEC source: 0001127602-23-018316 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,335 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.95 to $129.18. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:28 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,826 | $0.00 Strike: $123.79 | $0.00 |
DisclosureSEC source: 0001127602-23-017613 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,826 Underlying: Common Stock · 2,826 shares Expires 2033-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:28 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017613 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 302 Underlying: Common Stock · 302 shares Expires 2033-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:28 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017613 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 335 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:28 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017613 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2023 Filed May 3, 2023 00:55 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,072 | $125.00 | $259,000.00 |
DisclosureSEC source: 0001127602-23-014159 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,812 Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:14 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016535 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:14 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016535 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:14 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016535 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:14 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016535 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $55.70 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 21 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2025-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $39.64 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 20 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2024-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 1,000 | $0.00 Strike: $33.43 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 19 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2023-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 18 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 17 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 2,549 | $0.00 Strike: $69.03 | $0.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · derivative · entry 16 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,549 shares Expires 2028-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 401 | $139.03 | $55,751.03 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 15 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,072 Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $55.70 | $55,700.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 14 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 286 | $139.03 | $39,762.58 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 13 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,473 Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $39.64 | $39,640.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 12 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 241 | $139.03 | $33,506.23 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 11 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,759 Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $33.43 | $33,430.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 10 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,843 | $135.06 | $248,915.58 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 9 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,843 | $73.94 | $136,271.42 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 8 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,165 | $135.08 | $292,448.20 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 7 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.84. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,165 | $79.94 | $173,070.10 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 6 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,549 | $135.08 | $344,318.92 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 5 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.82. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,549 | $69.03 | $175,957.47 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 200 | $137.91 | $27,582.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.88 to $137.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,200 | $136.96 | $575,232.00 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,200 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.29 to $137.06. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 22:12 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 2,027 | $135.09 | $273,827.43 |
DisclosureSEC source: 0001127602-22-003422 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,400 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:55 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018896 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:55 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018896 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018896 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:55 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018896 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2020 Filed Sep 14, 2020 20:10 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 3,036 | $89.31 | $271,145.16 |
DisclosureSEC source: 0001127602-20-025035 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,906 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.16 to $89.44. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Cancel Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:28 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018657 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:28 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018657 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:28 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018657 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:28 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018657 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:57 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020745 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:57 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020745 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.